Cargando…
Concomitant Anti-GBM Glomerulonephritis and Acute Interstitial Nephritis Following Programmed Death Receptor-1 Blockade With Nivolumab
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546764/ https://www.ncbi.nlm.nih.gov/pubmed/36217512 http://dx.doi.org/10.1016/j.ekir.2022.08.020 |
| _version_ | 1784805116812984320 |
|---|---|
| author | Tani, Takashi Sugino, Kenta Hashimoto, Kazumasa Mii, Akiko Kashiwagi, Tetsuya Shimizu, Akira Sakai, Yukinao Iwabu, Masato |
| author_facet | Tani, Takashi Sugino, Kenta Hashimoto, Kazumasa Mii, Akiko Kashiwagi, Tetsuya Shimizu, Akira Sakai, Yukinao Iwabu, Masato |
| author_sort | Tani, Takashi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9546764 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95467642022-10-09 Concomitant Anti-GBM Glomerulonephritis and Acute Interstitial Nephritis Following Programmed Death Receptor-1 Blockade With Nivolumab Tani, Takashi Sugino, Kenta Hashimoto, Kazumasa Mii, Akiko Kashiwagi, Tetsuya Shimizu, Akira Sakai, Yukinao Iwabu, Masato Kidney Int Rep Letter to the Editor Elsevier 2022-08-29 /pmc/articles/PMC9546764/ /pubmed/36217512 http://dx.doi.org/10.1016/j.ekir.2022.08.020 Text en © 2022 International Society of Nephrology. Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Letter to the Editor Tani, Takashi Sugino, Kenta Hashimoto, Kazumasa Mii, Akiko Kashiwagi, Tetsuya Shimizu, Akira Sakai, Yukinao Iwabu, Masato Concomitant Anti-GBM Glomerulonephritis and Acute Interstitial Nephritis Following Programmed Death Receptor-1 Blockade With Nivolumab |
| title | Concomitant Anti-GBM Glomerulonephritis and Acute Interstitial Nephritis Following Programmed Death Receptor-1 Blockade With Nivolumab |
| title_full | Concomitant Anti-GBM Glomerulonephritis and Acute Interstitial Nephritis Following Programmed Death Receptor-1 Blockade With Nivolumab |
| title_fullStr | Concomitant Anti-GBM Glomerulonephritis and Acute Interstitial Nephritis Following Programmed Death Receptor-1 Blockade With Nivolumab |
| title_full_unstemmed | Concomitant Anti-GBM Glomerulonephritis and Acute Interstitial Nephritis Following Programmed Death Receptor-1 Blockade With Nivolumab |
| title_short | Concomitant Anti-GBM Glomerulonephritis and Acute Interstitial Nephritis Following Programmed Death Receptor-1 Blockade With Nivolumab |
| title_sort | concomitant anti-gbm glomerulonephritis and acute interstitial nephritis following programmed death receptor-1 blockade with nivolumab |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546764/ https://www.ncbi.nlm.nih.gov/pubmed/36217512 http://dx.doi.org/10.1016/j.ekir.2022.08.020 |
| work_keys_str_mv | AT tanitakashi concomitantantigbmglomerulonephritisandacuteinterstitialnephritisfollowingprogrammeddeathreceptor1blockadewithnivolumab AT suginokenta concomitantantigbmglomerulonephritisandacuteinterstitialnephritisfollowingprogrammeddeathreceptor1blockadewithnivolumab AT hashimotokazumasa concomitantantigbmglomerulonephritisandacuteinterstitialnephritisfollowingprogrammeddeathreceptor1blockadewithnivolumab AT miiakiko concomitantantigbmglomerulonephritisandacuteinterstitialnephritisfollowingprogrammeddeathreceptor1blockadewithnivolumab AT kashiwagitetsuya concomitantantigbmglomerulonephritisandacuteinterstitialnephritisfollowingprogrammeddeathreceptor1blockadewithnivolumab AT shimizuakira concomitantantigbmglomerulonephritisandacuteinterstitialnephritisfollowingprogrammeddeathreceptor1blockadewithnivolumab AT sakaiyukinao concomitantantigbmglomerulonephritisandacuteinterstitialnephritisfollowingprogrammeddeathreceptor1blockadewithnivolumab AT iwabumasato concomitantantigbmglomerulonephritisandacuteinterstitialnephritisfollowingprogrammeddeathreceptor1blockadewithnivolumab |